Shareholders Equity: The sum of preferred and common equity items.
ProQR Therapeutics N.V. (PRQR) had Shareholders Equity of $76.04M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$4.33M |
|
$-13.83M |
|
-- |
|
$4.33M |
|
$18.24M |
|
$-13.91M |
|
$0.10M |
|
$-13.81M |
|
$-13.81M |
|
$-13.83M |
|
$-13.83M |
|
$-13.83M |
|
$-13.83M |
|
$-13.91M |
|
$-13.08M |
|
105.34M |
|
105.34M |
|
$-0.14 |
|
$-0.14 |
|
| Balance Sheet Financials | |
$141.08M |
|
$15.05M |
|
$15.05M |
|
$156.13M |
|
$37.56M |
|
-- |
|
$42.53M |
|
$80.09M |
|
$76.04M |
|
$76.04M |
|
|
Shareholders Equity |
$76.04M |
107.71M |
|
| Cash Flow Statement Financials | |
$-30.88M |
|
$-0.37M |
|
$-0.90M |
|
$169.61M |
|
$135.96M |
|
$-33.65M |
|
$1.89M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.76 |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
100.00% |
|
-320.91% |
|
-320.91% |
|
-- |
|
-318.60% |
|
-319.07% |
|
$-31.25M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
-- |
|
-- |
|
-18.18% |
|
-18.18% |
|
-8.86% |
|
-18.18% |
|
$0.71 |
|
$-0.30 |
|
$-0.29 |
|